
Raphael Eric Steiner, M.D.
Department of Lymphoma - Myeloma, Division of Cancer Medicine
About Dr. Raphael Eric Steiner
Dr. Raphael Steiner, is an Assistant Professor in the Department of Lymphoma & Myeloma at the University of Texas MD Anderson Cancer Center. After a successful medical training in Switzerland in Internal Medicine/Family Practice and Medical Oncology, he completed a Lymphoma/Myeloma fellowship at MD Anderson Cancer Center. Dr. Steiner is currently Master Clinician in Lymphoma.
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
My clinical research focuses on creating innovative frontline treatments for high grade B-cell lymphoma and Hodgkin Lymphoma. Through optimal combination of immunotherapies and/or chemotherapies, I investigate new regimens to reduce the risk of relapse and decrease toxicities.
Clinical Interests
My clinical interests include high grade lymphomas (diffuse large B-cell lymphoma, Primary mediastinal B-cell lymphoma and Burkitt lymphoma) and Hodgkin lymphoma (classical Hodgkin Lymphoma and Nodular lymphocyte-predominant Hodgkin's lymphoma)
Education & Training
Degree-Granting Education
2006 | Lausanne University, Lausanne, CHE, MD, Master of Medicine |
2003 | Lausanne University, Lausanne, CHE, BS, Bachelor of Medicine |
Postgraduate Training
2016-2017 | Clinical Fellowship, Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX |
2014-2016 | Clinical Fellowship, Medical Oncology, Zurich University Hospital, Zurich |
2007-2013 | Clinical Residency, Internal Medicine/Family Practice, Zurich University Hospital, Zurich |
Board Certifications
2017 | Swiss Medical Association (FMH) in Medical Oncology |
2014 | Swiss Medical Association (FMH) in General Internal Medicine |
Experience & Service
Academic Appointments
Instructor, Department of General Oncology, Division of Cancer Medicine, County Hospital Aarau, Aarau, 2017 - 2018
Administrative Appointments/Responsibilities
Inpatient Medical Director, Lymphoma/Myeloma, Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX, 2022 - Present
Faculty Academic Review Committee, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Institutional Committee Activities
Member, Readmissions Review Committee, 2020 - Present
Member, IEC Steering Committee, 2020 - Present
Faculty member, Medical Records Committee, 2019 - Present
Honors & Awards
2021 | Scholar of the Leading Clinical Research Faculty Course, MD Anderson Cancer Center |
2020 | Scholar of Lymphoma Clinical Research Mentoring Program, Lymphoma Research Foundation |
2020 | Zero Hero (no EHR open encounter), 12/2020, 12/2022, DoCM State of the Division MD Anderson Cancer Center |
2020 | Top Speed EHR Closing Encounters, DoCM State of the Division MD Anderson Cancer Center |
2006 | Swiss Federal Examination in Medicine final boards insigni cum laude, Lausanne University |
2003 | Erasmus-Socrates European Union Grant, European Union |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Steiner RE, Parra ER, Vega F, Feng L, Westin JR, Neelapu SS, Strati P, Green MR, Flowers CR, Solis LM, Wistuba II, Ahmed S, Nair R, Hagemeister FB, Noorani M, Marques-Piubelli ML. PD-L1+ macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma. Exp Hematol Oncol Experimental Hematology & Oncology volume 12, Article number: 32 (2023)(1):32, 2023. e-Pub 2023. PMID: 36941707.
- Cherng HJ, Xu G, Feng L, Steiner R, Fayad L, Strati P, Nair R, Nastoupil LJ, Lee HJ, Neelapu SS, Flowers CR, Rodriguez M, Wang M, Hagemeister F, Pinnix CC, Ramdial J, Srour S, Nieto Y, Rezvani K, Champlin R, Kebriaei P, Westin J, Macapinlac HA, Shpall E, Ahmed S. Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant. Br J Haematol 200(1):35-44, 2023. e-Pub 2022. PMID: 36068929.
- Strati P, Jallouk AP, Sun R, Choi J, Das K, Cherng HJ, Ahmed S, Lee HJ, Iyer SP, Nair R, Nastoupil LJ, Steiner RE, Huff CD, Yu Y, Mistry H, Pulsifer B, Noorani M, Saini N, Shpall EJ, Kebriaei P, Flowers CR, Westin JR, Hildebrandt MAT, Neelapu SS. Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy. Leukemia 36(11):2669-2677, 2022. e-Pub 2022. PMID: 36127509.
- Saini NY, Swoboda DM, Greenbaum U, Ma J, Patel RD, Devashish K, Das K, Tanner MR, Strati P, Nair R, Fayad L, Ahmed S, Lee HJ, Iyer SP, Steiner R, Jain N, Nastoupil L, Loghavi S, Tang G, Bassett RL, Jain P, Wang M, Westin JR, Green MR, Sallman DA, Padron E, Davila ML, Locke FL, Champlin RE, Garcia-Manero G, Shpall EJ, Kebriaei P, Flowers CR, Jain MD, Wang F, Futreal AP, Gillis N, Neelapu SS, Takahashi K. Clonal hematopoiesis is associated with increased risk of severe neurotoxicity in axicabtagene ciloleucel therapy of large B-cell lymphoma. Blood Cancer Discov bloodcandisc.0177.2021. doi: 10.1158/2643-3230.BCD-21-0177(5):385-393, 2022. e-Pub 2022. PMID: 35533245.
- Han G, Deng Q, Marques-Piubelli ML, Dai E, Dang M, Ma MCJ, Li X, Yang H, Henderson J, Kudryashova O, Meerson M, Isaev S, Kotlov N, Nomie KJ, Bagaev A, Parra ER, Solis Soto LM, Parmar S, Hagemeister FB, Ahmed S, Iyer SP, Samaniego F, Steiner R, Fayad L, Lee H, Fowler NH, Flowers CR, Strati P, Westin JR, Neelapu SS, Nastoupil LJ, Vega F, Wang L, Green MR. Follicular lymphoma microenvironment characteristics associated with tumor cell mutations and MHC class II expression. Blood Cancer Discov 3(5):428-443, 2022. e-Pub 2022. PMID: 35687817.
- Cherng HJ, Sun R, Sugg B, Irwin R, Yang H, Le CC, Deng Q, Fayad L, Fowler NH, Parmar S, Steiner R, Hagemeister F, Nair R, Lee HJ, Rodriguez M, Samaniego F, Iyer SP, Flowers CR, Wang L, Nastoupil LJ, Neelapu SS, Ahmed S, Strati P, Green MR, Westin J. Risk assessment with low pass whole genome sequencing of cell free DNA before CD19 CAR T-cells for large B-cell lymphoma. Blood 140(5):504-515, 2022. e-Pub 2022. PMID: 35512184.
- Shbib Dabaja B, Boyce-Fappiano D, Dong W, Damron E, Fang P, Gunther J, Rodriguez MA, Strati P, Steiner R, Nair R, Lee H, Abou Yehia Z, Shihadeh F, Pinnix C, Ng AK. Second malignancies in patients with Hodgkin's Lymphoma: Half a century of experience. Clin Transl Radiat Oncol 2022 May 13;35:64-69. doi: 10.1016/j.ctro.2022.04.011. eCollection 2022 Jul:64-69, 2022. e-Pub 2022. PMID: 35601797.
- Steiner RE, Banchs J, Koutroumpakis E, Becnel M, Gutierrez C, Strati P, Pinnix CC, Feng L, Rondon G, Claussen C, Palaskas N, Karimzad K, Ahmed S, Neelapu SS, Shpall E, Wang M, Vega F, Westin J, Nastoupil LJ, Deswal A. Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma. Haematologica 2021 Nov 11. doi: 10.3324/haematol.2021.280009(7):1555-1566, 2022. e-Pub 2022. PMID: 34758610.
- Al Zaki A, Feng L, Watson G, Ahmed SA, Mistry H, Nastoupil LJ, Hawkins M, Nair R, Iyer SP, Lee HJ, Steiner RE, Flowers CR, Shpall EJ, Kebriaei P, Neelapu SS, Westin JR, Strati P. Day 30 SUVmax Predicts Progression in Lymphoma Patients Achieving PR/SD After CAR T-cell Therapy. Blood Adv 2022 Jan 11;bloodadvances.2021006715. doi: 10.1182/bloodadvances.2021006715(9):2867-2871, 2022. e-Pub 2022. PMID: 35015825.
- Akin S, Hosing C, Khouri I, Ahmed S, Alousi A, Fowler N, Joseph J, Truxillo J, Ramdial JL, Maadani F, Rondon G, Daher M, Im JS, Steiner R, Westin J, Iyer SP, Dabaja B, Anderlini P, Popat UR, Qazilbash MH, Flowers CR, Shpall E, Champlin RE, Nieto Y, Srour SA. Autologous Stem Cell Transplantation for Large B-cell Lymphoma with Secondary Central Nervous System Involvement. Blood Adv 2022 Jan 10;bloodadvances.2021005602. doi: 10.1182/bloodadvances.2021005602(7):2267-2274, 2022. e-Pub 2022. PMID: 35008100.
- Nieto Y, Gruschkus S, Valdez BC, Jones RB, Anderlini P, Hosing C, Popat U, Qazilbash M, Kebriaei P, Alousi A, Saini N, Srour S, Rezvani K, Ramdial J, Barnett M, Gulbis A, Shigle TL, Ahmed S, Iyer S, Lee H, Nair R, Parmar S, Steiner R, Dabaja B, Pinnix C, Gunther J, Cuglievan B, Mahadeo K, Khazal S, Chuang H, Champlin R, Shpall EJ, Andersson BS. Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis. Haematologica 107(4):899-908, 2022. e-Pub 2022. PMID: 33951890.
- Wang ML, Jain P, Zhao S, Lee HJ, Nastoupil L, Fayad L, Ok CY, Kanagal-Shamanna R, Hill HA, Yao Y, Hagemeister FB, Westin JR, Fowler N, Samaniego F, Steiner R, Nair R, Iyer SP, Navsaria L, Badillo M, Mantle Cell Research Group, Feng L, Xuelin H, Nogueras Gonzalez GM, Xu G, Wagner-Bartak N, Thirumurthi S, Santos D, Tang G, Lin P, Wang SA, Jorgensen J, Yin CC, Li S, Patel KP, Vega F, Medeiros LJ, Flowers CR, Wang L. Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial. Lancet Oncol Lancet Oncol . 2022 Jan 21;S1470-2045(21)00638-0. doi: 10.1016/S1470-2045(21)00638-0(3):406-415, 2022. e-Pub 2022. PMID: 35074072.
- Cherng HJ, Chuang HH, Steiner R, Fayad L, Strati P, Nair R, Hagemeister F, Nastoupil LJ, Lee HJ, Neelapu SS, Flowers CR, Samaniego F, Rodriguez M, Macapinlac HA, Feng L, Westin J. A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma. Leuk Lymphoma ;1-10. doi: 10.1080/10428194.2021.1971223(1):74-83, 2022. e-Pub 2021. PMID: 34435552.
- Al Feghali KA, Fang P, Gule-Monroe M, Milgrom S, Khoury JD, Gunther JR, Sheu T, Nair R, Ahmed S, Steiner R, Strati P, Shpall EJ, Nieto YL, Hosing C, Nastoupil LJ, Westin JR, Neelapu SS, Fowler N, Flowers C, Pinnix CC, Dabaja BS. Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy. Leuk Lymphoma 62(10):1-8, 2021. e-Pub 2021. PMID: 33942701.
- Greenbaum U, Strati P, Saliba RM, Torres J, Rondon G, Nieto Y, Hosing C, Srour SA, Westin J, Fayad LE, Lee HJ, Iyer SP, Nair R, Nastoupil LJ, Parmar S, Rodriguez MA, Samaniego F, Steiner RE, Wang M, Pinnix CC, Flowers CR, Tummala S, Ramdial JL, Yalniz FF, Hawkins M, Rezvani K, Champlin RE, Shpall EJ, Neelapu SS, Kebriaei P, Ahmed S. CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity. Blood Adv 2021 Jul 27;5(14):2799-2806. doi: 10.1182/bloodadvances.2021004575(14):2799-2806, 2021. PMID: 34264268.
- Augustyn A, Medeiros LJ, Ludmir EB, Gunther J, Fang P, Li S, Ok CY, Bankston ME, Verma V, Pasalic D, Ahmed S, Nastoupil LJ, Westin JR, Strati P, Neelapu SS, Nair R, Steiner RE, Iyer SP, Rodriguez A, Fayad LE, Flowers CR, Dabaja BS, Pinnix CC. The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy. Leuk Lymphoma 62(6):1-12, 2021. e-Pub 2021. PMID: 33480830.
- Strati P, Ahmed S, Furqan F, Fayad LE, Lee HJ, Iyer SP, Nair R, Nastoupil LJ, Parmar S, Rodriguez MA, Samaniego F, Steiner RE, Wang M, Pinnix CC, Horowitz SB, Feng L, Sun R, Claussen CM, Hawkins MC, Johnson NA, Singh P, Mistry H, Johncy S, Adkins S, Kebriaei P, Shpall EJ, Green MR, Flowers CR, Westin J, Neelapu SS. Prognostic Impact of Corticosteroids on Efficacy of Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma. Blood 137(23):3272-3276, 2021. e-Pub 2021. PMID: 33534891.
- Cabrera TB, Wang W, Yedururi S, Slopis JM, Steiner RE, Rytting ME, Cuglievan B. Coincidental Expression of Classic Hodgkin Lymphoma and Neurofibromatosis Type I and Literature Review. J Pediatr Hematol Oncol 43(4):e535-e538, 2021. PMID: 32366782.
- Mamlouk O, Nair R, Iyer SP, Edwards A, Neelapu SS, Steiner RE, Adkins SA, Hawkins M, Saini N, Devashish K, Strati P, Mandayam S, Ahmed S. Safety and Efficacy of CAR T-Cell Therapy in Kidney Transplant Recipients. Blood 137(18):2558-2562, 2021. e-Pub 2020. PMID: 33512386.
- Shaojun Zhang, Vivian Changying Jiang, Guangchun Han, Dapeng Hao, Junwei Lian, Yang Liu, Rongjia Zhang, Joseph McIntosh, Ruiping Wang, Minghao Dang, Enyu Dai, Yuanxin Wang, David Santos, Maria Badillo, Angela Leeming, Zhihong Chen, Kimberly Hartig, John Bigcal, Jia Zhou, Rashmi Kanagal-Shamanna, Chi Young Ok, Hun Lee, Raphael E Steiner, Jianhua Zhang, Xingzhi Song, Ranjit Nair, Sairah Ahmed, Alma Rodriquez, Selvi Thirumurthi, Preetesh Jain, Nicolaus Wagner-Bartak, Holly Hill, Krystle Nomie, Christopher Flowers, Andrew Futreal, Linghua Wang, Michael Wang. Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma. Nat Commun 2021 May 17;12(1):2877. doi: 10.1038/s41467-021-22872-z, 2021. PMID: 34001881.
- Fang P, Gunther JR, Pinnix CC, Dong W, Strati P, Nastoupil LJ, Steiner RE, Ahmed S, Damron EP, Fowler N, Nair R, Westin JR, Neelapu S, Ha CS, Dabaja BS. A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma. Int J Radiat Oncol Biol Phys 109(5):1414-1420, 2021. e-Pub 2020. PMID: 33309978.
- Strati P, Cheng PTM, Steiner RE, Alcedo Andrade PE, Feng L, Sano D, Rao VA, Singh P, Miranda R, Gunther JR, Pinnix CC, Dabaja BS, Cuglievan B, Xing K, Villa D, Skinnider B, Sehn LH, Connors JM, Nieto Y, Ahmed S, Lee HJ, Savage KJ. Outcome of relapsed and refractory nodular lymphocyte- predominant Hodgkin lymphoma: a North American analysis. Br J Haematol 192(2021 Feb;192(3):560-567. doi: 10.1111/bjh.17281):560-567, 2021. PMID: 33517581.
- Jain P, Nastoupil L, Westin J, Lee HJ, Navsaria L, Steiner RE, Ahmed S, Moghrabi O, Oriabure O, Chen W, Badillo M, Flowers CR, Wang ML. Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy. Br J Haematol 192(2):e38-e42, 2021. e-Pub 2020. PMID: 33152104.
- Furqan F, Watson G, Samaniego F, Fayad LE, Rashmi Kanagal-Shamanna , Morrison MW, Thompson PA, Steiner RE, Chi L, Dabaja B, Pinnix CC, Neelapu SS, Nastoupil LJ, Strati P. Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement. Leuk Lymphoma 61(12):2980-2984, 2020. e-Pub 2020. PMID: 32650677.
- Pinnix CC, Gunther JR, Fang P, Bankston ME, Milgrom SA, Boyce D, Lee HJ, Nair R, Steiner R, Strati P, Ahmed S, Iyer SP, Westin J, Parmar S, Rodriguez MA, Nastoupil L, Neelapu S, Flowers C, Dabaja BS. Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy. JAMA Netw Open 3(9):e2013935, 2020. e-Pub 2020. PMID: 32990738.
- Paolo Strati, Loretta J Nastoupil, Jason Westin, Luis E Fayad, Sairah Ahmed, Nathan H Fowler, Fredrick B Hagemeister, Hun J Lee, Swaminathan P Iyer, Ranjit Nair, Simrit Parmar, Maria A Rodriguez, Felipe Samaniego, Raphael E Steiner, Michael Wang, Chelsea C Pinnix, Sherry Adkins, Catherine M Claussen, Charles S Martinez, Misha C Hawkins, Nicole A Johnson, Prachee Singh, Haleigh E Mistry, Sandra Horowitz, Shirley George, Lei Feng, Partow Kebriaei, Elizabeth J Shpall, Sattva S Neelapu, Sudhakar Tummala, T Linda Chi. Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv, 2020. PMID: 32822484.
- Simbaqueba CC, Aponte MP, Kim P, Deswal A, Palaskas NL, Iliescu C, Jahangir E, Yang EH, Steiner RE, Lopez-Mattei J. Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy: The Cytokine Release Syndrome and Associated Arrhythmias. J Immunother Precis Oncol, 2020. PMID: 35663258.
- Chelsea C Pinnix, Jillian R Gunther, Bouthaina S Dabaja, Paolo Strati, Penny Fang, Misha C Hawkins, Sherry Adkins, Jason Westin, Sairah Ahmed, Luis Fayad, Hun Ju Lee, Ranjit Nair, Raphael E Steiner, Swaminathan P Iyer, M Alma Rodriguez, Michael Wang, Christopher Flowers, Sattva S Neelapu, Loretta J Nastoupil. Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma. Blood Adv, 2020. PMID: 32589728.
- Gordon Glober, Jillian Gunther, Penny Fang, Sarah Milgrom, Brinda Rao Korivi, Corey T Jensen, Nicolaus A Wagner-Bartak, Sairah Ahmed, Hun Ju Lee, Ranjit Nair, Raphael Steiner, Simrit Parmar, Swaminathan Iyer, Jason Westin, Luis Fayad, M Alma Rodriguez, Sattva Neelapu, Loretta Nastoupil, Christopher R Flowers, Bouthaina S Dabaja, Chelsea C Pinnix. Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission. Clin Lymphoma Myeloma Leuk, 2020. PMID: 32291233.
- Jillian R Gunther, Chelsea C Pinnix, Gordon R Glober, Kaitlin M Christopherson, Penny Fang, Hun Ju Lee, Sairah Ahmed, Raphael E Steiner, Ranjit Nair, Paolo Strati, Sattva S Neelapu, Loretta J Nastoupil, Bouthaina S Dabaja. Partial omission of bleomycin for early-stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?. EJHaem, 2020. PMID: 32864660.
- Strati P, Ahmed MA, Nastoupil LJ, Feng L, Hagemeister FB, Fayad LE, Rodriguez MA, Samaniego F, Wang M, Westin JR, Lee HJ, Iyer SP, Parmar S, Ahmed S, Nair R, Steiner RE, Noorani M, Flowers CR, Davis RE, Fowler NH, Neelapu SS. Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL. Leuk Lymphoma:1-8. e-Pub 2020. PMID: 31971032.
- Shuangtao Zhao, Rashmi Kanagal-Shamanna, Lucy Navsaria, Chi Young Ok, Shaojun Zhang, Krystle Nomie, Guangchun Han, Dapeng Hao, Holly A Hill, Changying Jiang, Yixin Yao, Loretta Nastoupil, Jason Westin, Luis Fayad, Ranjit Nair, Raphel Steiner, Sairah Ahmed, Felipe Samaniego, Swaminathan P Iyer, Onyeka Oriabure, Wendy Chen, Xingzhi Song, Jianhua Zhang, Maria Badillo, Omar Moghrabi, Jorge Aranda, Guilin Tang, C Cameron Yin, Keyur Patel, Leonard Jeffrey Medeiros, Shaoying Li, Francisco Vega, Selvi Thirumurthi, Guofan Xu, Sattva Neelapu, Christopher R Flowers, Jorge Romaguera, Nathan Fowler, Linghua Wang, Michael L Wang, Preetesh Jain. Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients. Am J Hematol, 2020. PMID: 32239765.
- Sunderland AJ, Steiner RE, Al Zahrani M, Pinnix CC, Dabaja BS, Gunther JR, Nastoupil LJ, Jerkeman M, Joske D, Cull G, El-Galaly T, Villa D, Cheah CY. An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement. Cancer Med 9(2):663-670, 2020. e-Pub 2019. PMID: 31808316.
- Gunther JR, Park C, Dabaja BS, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Garg N, Amini B, Steiner R, Nair R, Strati P, Westin JR, Lee HJ, Fowler N, Nastoupil L, Neelapu SS, Pinnix CC. Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function. Leuk Lymphoma 61(1):1-5, 2020. e-Pub 2019. PMID: 31373240.
- Akdeniz Dogan Z, Miranda RN, Iyer S, Steiner RE, Singh P, Clemens MW. Anaplastic Large Cell Lymphoma of the Breast Arising in a Burn Cicatrix. Aesthet Surg J, 2019.
- Pinnix CC, Milgrom SA, Cheah CY, Gunther JR, Ludmir EB, Wogan CF, Nastoupil LJ, Neelapu SS, Westin J, Lee HJ, Iyer SP, Steiner RE, Fayad LE, Fowler NH, Wang ML, Samaniego F, Rodriguez MA, Rich AE, Medeiros LJ, Dabaja BS. Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma. Blood Adv 3(9):1356-1367, 2019. PMID: 31036721.
- Chaudhry M, Steiner R, Claussen C, Patel K, Lee H, Weber D, Thomas S, Feng C, Amini B, Orlowski R, Feng L, Manasanch EE. Carfilzomib-based combination regimens are highly effective frontline therapies for multiple myeloma and Waldenström's macroglobulinemia. Leuk Lymphoma:1-7. e-Pub 2018. PMID: 30227761.
- Steiner R, Kridel R, Giostra E, McKee T, Achermann R, Mueller N, Manuel O, Dickenmann M, Schuurmans MM, de Leval L, Fehr T, Tinguely M, Binet I, Cogliatti S, Haralamvieva E, Koller M, The Swiss Transplant Cohort Study Stcs , Dietrich PY. Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland. Swiss Med Wkly 148:w14596, 2018. e-Pub 2018. PMID: 29518251.
- Steiner RE, Orlowski RZ, Lee HC. Acute Pancreatitis Associated with Ixazomib in a Multiple Myeloma Patient. Acta Haematol 139(1):67-70, 2018. e-Pub 2018. PMID: 29402766.
- Steiner RE, Romaguera J, Wang M. Current trials for frontline therapy of mantle cell lymphoma. J Hematol Oncol 11(1):13, 2018. e-Pub 2018. PMID: 29374487.
- Steiner RE, Manasanch EE. Carfilzomib boosted combination therapy for relapsed multiple myeloma. Onco Targets Ther 10:895-907, 2017. e-Pub 2017. PMID: 28243125.
- Steiner R, Beyer J. [Post treatment follow-up of patients with testicular cancer by primary care physicians]. Praxis (Bern 1994) 103(3):125-32; quiz 131, 2014. PMID: 24468451.
Manuals, Teaching Aids, Other Teaching Publications
- R. Steiner, J. Westin, O. FLeckenstein, S. Horowitz, L.J. Medeiros, C. Pinnix, H. Warr, M.L. Warren. MDACC algorithm AIDS-Related B-Cell and Burkitt Lymphomas: MDACC, 2023.
- R. Steiner, D. Gombos. Lymphomas of the eye. Webpage of MD Anderson Cancer Center, 2023.
Abstracts
- Mario L. Marques-Piubelli, MD, Daniela Dueñas, MD, Lianqun Qiu, MD, PhD, Karen Nahmod, MD, PhD, Jeong Hee Cho, MD, PhD, Mei Jiang, Salome McAllen, Luisa M Solis Soto, MD, Raphael Steiner, MD, Chelsea C. Pinnix, MD, PhD, Ignacio I. Wistuba, MD, Edwin R. Parra, MD, PhD and Francisco Vega, MD, PhD. EOMES+ Tr1-like Cells Are Enriched in Areas of NLPHL Group II (Patterns D to F) Supporting the Role of Tregs in Disease Recurrence/Progression. Blood, 2022.
- Xubin Li, Qing Deng, PhD, Jared Henderson, PhD, Grace Watson, Laurel Deaton, Taylor Cain, Luis Fayad, MD, Swaminathan Padmanabhan Iyer, MD, Fredrick B. Hagemeister, MD, Loretta J. Nastoupil, MD, Nathan H. Fowler, MD, Jason Westin, MD, Raphael Steiner, MD, Ranjit Nair, MD, Sairah Ahmed, MD, Gheath Alatrash, PhD, DO, Sattva S. Neelapu, MD, Paolo Strati, MD and Michael R. Green, PhD. Targetable Cellular Etiology of Prolonged Cytopenia Following CD19 CAR T-Cell Therapy. Blood, 2022.
- Kevin Tang, MD, Raamis Khwaja, MD, Lei Feng, MS, Paolo Strati, MD, Raphael E Steiner, MD, Ranjit Nair, MD, Christopher R. Flowers, MD, Neeraj Saini, MD, Jeremy L. Ramdial, MD, Samer A Srour, MD, MS, Richard E Champlin, MD, Gabriela Rondon, MD, Janet Torres, Partow Kebriaei, MD, Loretta J. Nastoupil, MD, Haleigh Mistry, Elizabeth J Shpall, MD, Yago Nieto, MD, Jason Westin, MD, Sattva S. Neelapu, MD and Sairah Ahmed, MD. Comorbidities Associated with Early Mortality after CD19 CAR-T Cell Therapy. Blood, 2022.
- Yago Nieto, MD, Benigno C Valdez, PhD, Peter F Thall, PhD, Jeremy L. Ramdial, MD, Samer A Srour, MD, MS, Chitra Hosing, MD, Neeraj Saini, MD, Amin M Alousi, MD, Muzaffar H Qazilbash, MD, Uday R Popat, MD, Alison Gulbis, PharmD, Terri Lynn Shigle, PharmD, Roland Bassett, MS, Maria Guillermo-Pacheco, Celina Ledesma, Paolo Strati, MD, Sairah Ahmed, MD, Raphael Steiner, MD, Jason Westin, MD, Ranjit Nair, MD, Swaminathan P. Iyer, MD, Richard E Champlin, MD, Elizabeth J Shpall, MD and Borje S Andersson, MD, PhD. High Efficacy of the PARP Inhibitor Olaparib Combined with High-Dose Chemotherapy and Autologous Stem-Cell Transplant for Refractory Lymphomas. Blood, 2022.
- Ranjit Nair, MD, Amy Ayers, MPH, Loretta J. Nastoupil, MD, Jillian R. Gunther, MD, PhD*, Luis Fayad, MD, Nathan H. Fowler, MD, Roberto N. Miranda, MD, Fredrick B. Hagemeister, MD, Hun Ju Lee, MD, Maria Alma Rodriguez, MD, Raphael Steiner, MD, Paolo Strati, MD, Yago Nieto, MD, Jeremy L. Ramdial, MD, Dai Chihara, MD, Michael L. Wang, MD, Luis E Malpica Castillo, MD, Neeraj Saini, MD, Preetesh Jain, MBBS, MD, DM, PhD, Chelsea C. Pinnix, MD, PhD, Bouthaina S. Dabaja, MD, Michael R. Green, PhD, Christopher R. Flowers, MD, L. Jeffrey Medeiros, MD, Mario L. Marques-Piubelli, MD, Francisco Vega, MD, PhD, Mansoor Noorani, Sairah Ahmed, MD, Jason Westin, MD, Sattva S. Neelapu, MD, Lei Feng, MS and Swaminathan Padmanabhan Iyer, MD. CD19 CAR-T Outcomes in Patients with EBV-Positive DLBCL. Blood, 2022.
- Owhofasa O. Agbedia, MD, MPH, Rishab Prakash, BS, Jie Xu, MD, Melody R. Becnel, MD, Ranjit Nair, MD, Raphael E Steiner, MD, Lei Feng, MS, Hun Ju Lee, MD, Paolo Strati, MD, Sairah Ahmed, MD, Simrit Parmar, MD, MSC, Yago Nieto, MD, Chitra Hosing, MD, Jason Westin, MD, Loretta J. Nastoupil, MD, Ann Vo, Felipe Samaniego, MD, Nathan H. Fowler, MD, Neeraj Saini, MD, Issa F. Khouri, MD, Jin S. Im, MD, PhD, Luis Fayad, MD, Preetesh Jain, MBBS, MD, DM, PhD, Michael L. Wang, MD, Roberto N. Miranda, MD, Francisco Vega, MD, PhD, Jeffrey Medeiros, MD, PhD, Yasuhiro Oki, Christopher R. Flowers, MD, Sattva S. Neelapu, MD and Swaminathan P. Iyer, MD. Updated Results of an Investigator-Initiated Phase II Study of Pembrolizumab and Romidepsin for Patients with Relapsed or Refractory T-Cell Lymphoma (TCL) with Survival Analysis. Blood, 2022.
- Angela Sheng, MD, Max J. Gordon, MD, Sairah Ahmed, MD, Raphael E Steiner, MD, Paolo Strati, MD, Jason Westin, MD, Chitra Hosing, MD, Partow Kebriaei, MD, Elizabeth J Shpall, MD, Sattva S. Neelapu, MD and Loretta J. Nastoupil, MD. Association of the CLL Comorbidity Index (CLL-CI) and International Prognostic Index (IPI) with Overall Survival (OS) and 1-Year Mortality in Patients (pts) with Relapsed or Refractory (r/r) Large B Cell Lymphoma (LBCL) Treated with CD19 Directed Autologous Chimeric Antigen Receptor T (CART) Cell Therapies. Blood, 2022.
- Andrew Jallouk, MD, PhD, Lei Feng, MS, Mansoor Noorani, Kaberi Das, Raphael E Steiner, MD, Loretta J. Nastoupil, MD, Misha Hawkins, Ranjit Nair, MD, Jason Westin, MD, Luis Fayad, MD6, Dai Chihara, MD, Luis Enrique Malpica Castillo, MD, Swaminathan P. Iyer, MD, Sairah Ahmed, MD, Elizabeth J Shpall, MD, Partow Kebriaei, MD, Sattva S. Neelapu, MD and Paolo Strati, MD. Effect of Delayed Cell Infusion in Patients with Large B-Cell Lymphoma Treated with CAR T-Cell Therapy. Blood, 2022.
- Paolo Strati, MD, Xubin Li, Qing Deng, PhD, Lei Feng, MS, Ryan Sun, MD, Andrew Jallouk, MD, PhD, Sherry Adkins, ANP, Taylor Cain, Swapna Johncy8, Raphael E Steiner, MD, Sairah Ahmed, MD, Dai Chihara, MD, PhD, Luis Fayad, MD, Swaminathan Padmanabhan Iyer, MD, Sandra B. Horowitz, Pharm.D, Rachel Nehlsen, Loretta J. Nastoupil, MD, Ranjit Nair, MD, Ahmed Hassan2, Taher Daoud2, Misha Hawkins14, Felipe Samaniego, MD1, Maria Alma Rodriguez, MD6, Elizabeth J Shpall, MD, Partow Kebriaei, MD, Christopher R. Flowers, MD, David Hong2, Jason Westin, MD, Sattva S. Neelapu, MD and Michael R. Green, PhD. Primary Analysis of a Pilot Study of Prophylactic Anakinra to Mitigate CAR T Cell-Associated Toxicity in Patients with Relapsed or Refractory Large B-Cell Lymphoma. Blood, 2022.
- Preetesh Jain, MBBS, MD, DM, PhD, Chi Young Ok, MD, Ahmed Fetooh, Rashmi Kanagal-Shamanna, MD, Fatima Zahra Jelloul, MD, Holly Hill, Kristen Floyd, Sanam Loghavi, MD, Zhuang Zuo, MD, C. Cameron Yin, MD, PhD, Mark Routbort, MD, PhD, Guilin Tang, MD, PhD, Sairah Ahmed, MD, Luis Enrique Malpica Castillo, MD, Asiya Siddiqui, Wendy Chen, Onyeka Oriabure, Maria Badillo, MSN, RN, OCN, CCRP5, Raphael E Steiner, MD, Swaminathan P. Iyer, MD, Hun Ju Lee, MD, Rajyalakshmi Luthra, PhD2, Francisco Vega, MD, PhD, Christopher R. Flowers, MD, Jeffrey Medeiros, MD, PhD, Michael L. Wang, MD, Keyur P. Patel, MBBS, PhD, Nathan H. Fowler, MD, and Ranjit Nair, MD. Mutation Spectrum, Characteristics and Impact of Mutation Profiling on Prognosis, Outcome and Treatment Responses in Patients (pts) with Mantle Cell Lymphoma. Blood, 2022.
- Chelsea C. Pinnix, MD, PhD, Bouthaina S. Dabaja, MD, Jillian R. Gunther, MD, PhD, Penny Fang, MD, Susan Wu, MD, Sairah Ahmed, MD, Raphael E Steiner, MD, Ranjit Nair, MD, Paolo Strati, MD, Jason Westin, MD, Luis Fayad, MD, Swami P. Iyer, MD, Maria Alma Rodriguez, MD, Hun Ju Lee, MD, Felipe Samaniego, MD, Dai Chihara, MD, Preetesh Jain, MBBS, MD, DM, PhD, Lei Feng, M, Christopher R. Flowers, MD, Sattva S. Neelapu, MD and Loretta J. Nastoupil, MD. Phase II Study of Pembrolizumab and Fractionated External Beam Radiotherapy in Patients with Relapsed and Refractory Large B-Cell Lymphoma. Blood, 2022.
- Ranjit Nair, Rishab Prakash, Anna Dang, Jillian R. Gunther, Auris Huen, Jie Xu, Luis Enrique Malpica Castillo, Carlos Torres Cabala, Meghan Heberton, Penny Fang, Sairah Ahmed, Roberto N. Miranda, Luis Fayad, Raphael Steiner, Hun Ju Lee, Dai Chihara, Preetesh Jain, Samer A Srour, Jeremy L Ramdial, Yago Nieto, Loretta J. Nastoupil, Chelsea C. Pinnix, Sattva S. Neelapu, Christopher R. Flowers, L. Jeffrey Medeiros, Chitra Hosing, Michael L. Wang, Bouthaina S. Dabaja, Francisco Vega, Lei Feng, Swaminathan Padmanabhan Iyer. Cutaneous/ Subcutaneous Involvement - an Immuneprivileged Site Associated with Poor Outcomes in Systemic Peripheral T/ NK Cell Lymphoma. Blood Blood (2022) 140 (Supplement 1): 12005–12007, 2022.
- Serageldin Kamel, Joo Schmidt, Eslam Aboismail, Lucia L Martini, Sairah Ahmed, Ranjit Nair, Raphael E Steiner, Michael L. Wang, Gregory Ravizzini, Sarita Soebianto, Tinsu Pan, Jillian R. Gunther, Chelsea C. Pinnix, Hun Ju Lee. Prognostic Value of Body Composition in a Cohort of Elderly Pts with Newly Diagnosed Classical Hodgkin's Lymphoma: A Retrospective Single Center Study. Blood Blood (2022) 140 (Supplement 1): 13020–13022, 2022.
- Omar Mamlouk, Paolo Strati, Lei Feng, Ryan Sun, Raphael Eric Steiner, Ranjit Nair, Christopher Flowers, Jeremy L Ramdial, Neeraj Saini, Samer Ali Srour, Richard E. Champlin, Partow Kebriaei, Loretta J. Nastoupil, Maria Alma Rodriguez, Elizabeth J. Shpall, Yago Nieto, Jason Westin, Sattva Swarup Neelapu, Sreedhar Mandayam, Sairah Ahmed. Real-world analysis of safety and efficacy of CAR T-cell therapy in patients with lymphoma with decreased renal function. J Clin Oncol, 2022.
- Raphael Eric Steiner, Paolo Strati, Christopher Flowers, Sattva Swarup Neelapu, Michael Richard Green, Loretta J. Nastoupil, Fredrick B. Hagemeister, Lei Feng, Sairah Ahmed, Ranjit Nair, Luis Fayad, Hun Ju Lee, Maria Alma Rodriguez, Jason Westin. Brentuximab vedotin and nivolumab alone and then combined with rituximab, cyclophosphamide, doxorubicin, and prednisone for frontline therapy of patients with primary mediastinal large B-cell lymphoma. J Clin Oncol, 2022.
- Raphael Steiner, Paolo Strati, Christopher Flowers, Sattva Neelapu, Michael Green, Loretta Nastoupil, Fredrick Hagemeister, Lei Feng, Sairah Ahmed, Ranjit Nair, Luis Fayad, Hun Lee, Maria Alma Rodriguez, Jason Westin. PACIFIC: BRENTUXIMAB VEDOTIN AND NIVOLUMAB ALONE AND THEN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE FOR UNTREATED PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA PATIENTS. EHA Hemasphere, 2022.
- Sushanth Gouni, Jason R. Westin, Haleigh Mistry, Raphael Eric Steiner, Jinsu James, Simrit Parmar, Mansoor Noorani, Nathan H. Fowler, Sandra B. Horowitz, Lei Feng, Luis E. Fayad, Swaminathan P Iyer, Michael R Green, Misha Hawkins, Christopher R. Flowers, Sairah Ahmed, Loretta Nastoupil, Sattva S. Neelapu, Yago Nieto, Paolo Strati. Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma Patients in Complete Metabolic Response at Time of Infusion. Blood Blood (2021) 138 (Supplement 1): 1740, 2021.
- Liana Nikolaenko, Timothy Pardee, Raphel Steiner, Jeremy S. Abramson, Steven M. Horwitz, Matthew J. Matasar, Colette Owens, Ildefonso Rodriguez-Rivera, David J. Straus, Sanjeev Luther, Ariela Noy. Complete Remission with Devimistat (CPI-613) in Refractory Burkitt Lymphoma. Blood Blood (2021) 138 (Supplement 1): 4555, 2021.
- Ranjit Nair, Nafis Deen, Sairah Ahmed, Roberto N. Miranda, Nathan H. Fowler, Luis Fayad, Raphael E Steiner, Fredrick B. Hagemeister, Maria Alma Rodriguez, Hun Ju Lee, Paolo Strati, Luis Malpica-Castillo, Dai Chihara, Preetesh Jain, Jillian R. Gunther, Christopher R. Flowers, L. Jeffrey Medeiros, Yago Nieto, Jeremy L. Ramdial, Sattva S. Neelapu, Loretta Nastoupil, Michael R Green, Michael Wang, Francisco Vega, Lei Feng, Swaminathan Padmanabhan Iyer, Jason R. Westin. Outcome of Patients with T- Cell Histiocyte Rich B Cell Lymphoma: Single Institution Series. Blood Blood (2021) 138 (Supplement 1): 1448, 2021.
- Raphael E Steiner, Paolo Strati, Christopher R. Flowers, Sattva S. Neelapu, Michael R Green, Loretta Nastoupil, Fredrick B. Hagemeister, Lei Feng, Sairah Ahmed, Ranjit Nair, Luis Fayad, Hun Ju Lee, Maria Alma Rodriguez, Jason R. Westin. Pacific: A Phase II Study of Brentuximab Vedotin and Nivolumab Alone and then Combined with Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Patients with Untreated Primary Mediastinal Large B-Cell Lymphoma. Blood Blood (2021) 138 (Supplement 1): 1408, 2021.
- Luis Malpica-Castillo, Lei Feng, Jie Xu, Ranjit Nair, Alexandra Elias, Preetesh Jain, Dai Chihara, Raphael Steiner, Luis Fayad, Felipe Samaniego, Sairah Ahmed, Nathan H. Fowler, Loretta Nastoupil, Samer A. Srour, Yago Nieto, Chitra Hosing, Roberto N. Miranda, Francisco Vega, Chelsea C. Pinnix, Jillian R. Gunther, Penny Fang, Susan Wu, Bouthaina S. Dabaja, Jeffrey Medeiros, Michael Wang, Sattva S. Neelapu, Christopher R. Flowers, Swaminathan Padmanabhan Iyer. Long Term Outcome Patterns and Risk Factors for Early Mortality and Disease Progression in ALK-Positive Anaplastic Large Cell Lymphoma. Blood Blood (2021) 138 (Supplement 1): 2463, 2021.
- Jason R. Westin, Raphael Steiner, Lei Feng, Paolo Strati, Christopher R. Flowers, Sattva S. Neelapu, Loretta Nastoupil, Dai Chihara, Fredrick B. Hagemeister, Sairah Ahmed, Ranjit Nair, Luis Fayad, Hun Ju Lee, Maria Alma Rodriguez, Eric Davis, Michael R Green. Smart Stop: A Phase II Study of Lenalidomide, Tafasitamab, Rituximab, and Acalabrutinib Alone and with Chemotherapy in Patients with Newly Diagnosed DLBCL. Blood Blood (2021) 138 (Supplement 1): 3572, 2021.
- Chelsea C. Pinnix, Bouthaina S. Dabaja, Jillian R. Gunther, Penny Fang, Susan Wu, Loretta Nastoupil, Paolo Strati, Ranjit Nair, Sairah Ahmed, Raphael E Steiner, Luis Malpica-Castillo, Dai Chihara, Preetesh Jain, Luis Fayad, Jason R. Westin, Sattva S. Neelapu, Maria Alma Rodriguez, Fredrick B. Hagemeister, Hun Ju Lee, Michael Wang, Felipe Samaniego, Nathan H. Fowler, Christopher R. Flowers, Lei Feng, Linda Chi, Bita Esmaeli. Phase II Trial of Response Adapted Ultra Low Dose (ULD) Orbital Radiation Therapy for Indolent B Cell Lymphoma. Blood Blood (2021) 138 (Supplement 1): 3526, 2021.
- Ajlan Al Zaki, Jason R. Westin, Grace Watson, Lei Feng, Sairah Ahmed, Haleigh Mistry, Loretta Nastoupil, Misha Hawkins, Ranjit Nair, Swaminathan P Iyer, Hun Lee, Raphael E Steiner, Christopher R. Flowers, Elizabeth J. Shpall, Partow Kebriaei, Sattva S. Neelapu, Paolo Strati. Analysis of Factors Associated with Conversion to CR in Patients with Large B-Cell Lymphoma Achieving Day 30 PR after CAR T-Cell Therapy. Blood Blood (2021) 138 (Supplement 1): 3870, 2021.
- Serageldin Kamel, Li-Wei Chen, Gregory Ravizzini, Ho-Feng Chen, Joo Schmidt, Sairah Ahmed, Ranjit Nair, Raphael E Steiner, Branko Cuglievan, Yago Nieto, Roberto N. Miranda, Penny Fang, Jillian R. Gunther, Chelsea C. Pinnix, Michael Wang, Tinsu Pan, Hun Ju Lee. Radiomic Phenotypes of High and Low Lesion SUV Components for the Prediction of Refractory Disease in Hodgkin's Lymphoma Patients Treated with ABVD Based Therapy. Blood Blood (2021) 138 (Supplement 1): 3996, 2021.
- Ranjit Nair, Lei Feng, Jillian R. Gunther, Jie Xu, Luis Malpica-Castillo, Auris Huen, Carlos Torres Cabala, Meghan Heberton, Penny Fang, Sairah Ahmed, Roberto N. Miranda, Luis Fayad, Raphael Steiner, Hun Ju Lee, Dai Chihara, Preetesh Jain, Samer A. Srour, Yago Nieto, Loretta Nastoupil, Chelsea C. Pinnix, Sattva S. Neelapu, Christopher R. Flowers, L. Jeffrey Medeiros, Chitra Hosing, Michael Wang, Bouthaina S. Dabaja, Francisco Vega, Swaminathan Padmanabhan Iyer. Outcomes of Patients with Extranodal Natural Killer/T-Cell Lymphoma: Single Institution Series. Blood Blood (2021) 138 (Supplement 1): 4536, 2021.
- Hua-Jay J. Cherng, Ryan Sun, Haopeng Yang, Qing Deng, Luis Fayad, Nathan H. Fowler, Simrit Parmar, Sairah Ahmed, Raphael E Steiner, Fredrick B. Hagemeister, Hun Ju Lee, Ranjit Nair, Maria Alma Rodriguez, Felipe Samaniego, Swaminathan P Iyer, Loretta Nastoupil, Sattva S. Neelapu, Paolo Strati, Jason R. Westin, Michael R Green. A Risk Score Incorporating Low Pass Whole Genome Sequencing of Cell Free DNA from Patients Receiving CD19 CAR T-Cell Therapy for Large B-Cell Lymphoma. Blood Blood (2021) 138 (Supplement 1): 38, 2021.
- Sophia Lee, Christen Dillard, Raphael E Steiner, Babak Soltanalizadeh, Lei Feng, Sanam Loghavi, Sairah Ahmed, Krina K. Patel. Outcomes in Advanced-Stage Plasmablastic Lymphoma. Blood Blood (2021) 138 (Supplement 1): 2519, 2021. e-Pub 2021.
- L. Nikolaenko1 , T. S. Pardee , R. Steiner , J. S. Abramson , S. Horwitz , M. Matasar , C. Owens , I. Rodriguez‐Rivera , D. Straus , S. Luther , A. Noy. PRELIMINARY ACTIVITY OF DEVIMISTAT (CPI 613) IN PATIENTS WITH RELAPSED OR REFRACTORY BURKITT LYMPHOMA/LEUKEMIA. Hematological ONCOLOGY Vol. 39 Supp. 2 June 2021 ISSN 0278–0232, 2021.
- R. Steiner, J. Banchs, E. Koutroumpakis, M. Becnel, C. Gutierrez, P. Strati, C. Pinnix, L. Feng, C. Claussen, N. Palaskas , K. Karimzad, S. Ahmed, S. Neelapu , E. Shpall, M. Wang, F. Vega , J. Westin , L. Nastoupil , A. Deswal. CARDIOVASCULAR EVENTS AMONG ADULT PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA TREATED WITH STANDARD OF CARE AXICABTAGENE CILOLEUCEL AND TISAGENLECLEUCEL. Hematological ONCOLOGY Vol. 39 Supp. 2 June 2021 ISSN 0278–0232, 2021.
- Uri Greenbaum, MD, Paolo Strati, MD, Rima M. Saliba, PhD, Janet Torres, Gabriela Rondon, Yago Nieto, MD, Chitra Hosing, MD, Samer A. Srour, MD MS, Jason Westin, MD, Luis Fayad, Hun Ju Lee, MD, Swaminathan P Iyer, MD, Loretta J. Nastoupil, MD, Simrit Parmar, MD, MSCI, Maria Alma Rodriguez, MD, Felipe Samaniego, MD, Raphael Eric Steiner, MD, Michael Wang, MD, Chelsea C. Pinnix, MD PhD, Christopher Flowers, MDMS, Sudhakar Tummala, MD, Jeremy Ramdial, MD, Fevzi F. Yalniz, Misha Hawkins, Katayoun Rezvani, MD PhD, Richard E. Champlin, MD, Elizabeth J. Shpall, MD, Sattva S. Neelapu, MD, Partow Kebriaei, MD, Sairah Ahmed, MD. The Easix (Endothelial Activation and Stress Index) Score Predicts for CAR T Related Toxicity in Patients Receiving Axicabtagene Ciloleucel (axi-cel) for Non-Hodgkin Lymphoma (NHL). Blood(Blood (2020) 136 (Supplement 1): 17–18), 2020.
- Hua-Jay J Cherng, MD, Raphael E Steiner, MD, Luis Fayad, Paolo Strati, MD, Ranjit Nair, MD, F. B. B. Hagemeister, MD, Loretta J. Nastoupil, MD, Hun Ju Lee, MD, Sattva S. Neelapu, MD, Christopher Flowers, MDMS, Felipe Samaniego, MD, Maria Alma Rodriguez, MD, Lei Feng, MS, Hubert Chuang, MDPhD, Jason R. Westin, MD. Persistent Overall Response on Early PET/CT Scans during Salvage Therapy for Relapsed or Refractory DLBCL Predicts for Disease Specific Survival. Blood(Blood (2020) 136 (Supplement 1): 7–8), 2020.
- Preetesh Jain, MBBS,MDDM,PhD, Yixin Yao, PhD, Shuangtao Zhao, PhD, Yang Liu, PhD, Holly Hill, Yuxuan Che, Yijing Li, MS, Alexa A Jordan, BS, Joseph McIntosh, BS, Hun Ju Lee, MD, Raphael Eric Steiner, MD, Felipe Samaniego, MD, Jason Westin, MD, Loretta J. Nastoupil, MD, Ranjit Nair, Sairah Ahmed, MD, Chi Young Ok, MD, Rashmi Kanagal-Shamanna, MD, Onyeka Oriabure, Guofang Xu, MD, Wendy Chen, Omar Moghrabi, Chloe Marie McClain, Maria Badillo, MSN, RN, OCN, CCRP, Selvi Thirumurthi, David Santos, Cezar Iliescu, MD, C. Cameron Yin, MD PhD, Shaoying Li, MD, Guilin Tang, MD, Francisco Vega, MDPhD, Sattva S. Neelapu, MD, Christopher Flowers, MDMS, Linghua Wang, PhD, Michael Wang, MD. Combination of Ibrutinib with Rituximab (IR) in Previously Untreated Older Patients with Mantle Cell Lymphoma (MCL) - a Phase II Clinical Trial. Blood(Blood (2020) 136 (Supplement 1): 41–42), 2020.
- Carla Casulo, MD, Myla Strawderman, MS, Raphael Steiner, MD, Carolyne Delage, MD, Tina Faugh, Matthew J. Maurer, MS, Brian K. Link, MD, Allison C. Rosenthal, D.O., Colleen Ramsower, B.S. M.B., Richard Burack, MD PhD, Sergei Syrbu, MD PhD, Andrew L. Feldman, MD, Philip J Rock, James R. Cerhan, MD PhD, Christopher Flowers, MDMS, Lisa M. Rimsza, MD, Jonathan W. Friedberg, MD MSSc. Describing Treatment of Primary Mediastinal Large B Cell Lymphoma Using Rigorously Defined Molecular Classification: A Retrospective Analysis. Blood(Blood (2020) 136 (Supplement 1): 35–36), 2020.
- Neeraj Saini, MD, Chia-Chi Chang, PhD, Paolo Strati, MD, Loretta J. Nastoupil, MD, Jason Westin, MD, Ranjit Nair, MD, Luis Fayad, Sairah Ahmed, MD, Hun Ju Lee, MD, Swaminathan P Iyer, MD, Raphael Eric Steiner, MD, Uri Greenbaum, MD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Nitin Jain, MD, Michael R Green, PhD, Nadim J Ajami, Christopher Flowers, MDMS, Richard E. Champlin, MD, Jennifer Wargo, MD, Sattva S. Neelapu, MD, Robert R. Jenq, MD. Gut Bacterial Diversity Associates with Efficacy of Anti-CD19 CAR T-Cell Therapy in Patients with Large B-Cell Lymphoma. Blood(Blood (2020) 136 (Supplement 1): 34–35), 2020.
- Paolo Strati, MD, Haleigh Mistry, Brittany Pulsifer, Luis Fayad, Sairah Ahmed, MD, Hun Ju Lee, MD, Swami P. Iyer, MD, Ranjit Nair, MD, Loretta J. Nastoupil, MD, Simrit Parmar, MD, MSCI, Maria Alma Rodriguez, MD, Felipe Samaniego, MD, Raphael Eric Steiner, MD, Michael Wang, MD, Chelsea C. Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Mansoor Noorani, Catherine M. Claussen, MS, Elizabeth J. Shpall, MD, Partow Kebriaei, MD, Chris R. Flowers, MD MS, Jason R. Westin, MD, Sattva S. Neelapu, MD. Prognostic Value of Delta Lymphocyte Index (DLIx) in Patients with Large B-Cell Lymphoma (LBCL) Treated with Chimeric Antigen Receptor (CAR) T-Cell Therapy. Blood(Blood (2020) 136 (Supplement 1): 23–24), 2020.
- Yago Nieto, MD, Stephen K. Gruschkus, PhD MPH, Roy B. Jones, MD PhD, Benigno C. Valdez, PhD, Melissa Timmons, PA-C, Chitra Hosing, MD, Paolo Anderlini, Partow Kebriaei, MD, Uday R. Popat, MD, Muzaffar H. Qazilbash, MD, Amin M. Alousi, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Jeremy Ramdial, MD, Jin S. Im, Elizabeth J. Shpall, MD, Katayoun Rezvani, MD PhD, Alison Gulbis, Terri Lynn Shigle, PharmD, Kris Michael Mahadeo, MD, Sajad Khazal, MD, Issa F. Khouri, MD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD PhD, Jillian R. Gunther, MD PhD, Hun Lee, MD, Sairah Ahmed, MD, Raphael Eric Steiner, MD, Swaminathan P Iyer, MD, Ranjit Nair, MD, Simrit Parmar, MD, MSCI, Branko Cuglievan, MD, Farzaneh Maadani, BS, MT, Gabriela Rondon, Richard E. Champlin, MD, Borje S. Andersson, MD, PhD. Factors Associated with the Improvement of Outcomes of High-Risk Relapsed Hodgkin Lymphoma (HL) Patients Receiving High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT): The MD Anderson Cancer Center Experience. Blood(Blood (2020) 136 (Supplement 1): 17–18), 2020.
- Preetesh Jain, MBBS,MDDM,PhD, Rashmi Kanagal-Shamanna, MD, Lucy Navsaria, MB BCh BAO, Chi Young Ok, MD, Holly Hill, Dayoung Jung, Graciela M. Nogueras González, MPH, Hun Ju Lee, MD, Ranjit Nair, Sairah Ahmed, MD, Raphael Eric Steiner, MD, Guilin Tang, MD, Shaoying Li, MD, Keyur Patel, MD PhD, Selvi Thirumurthi, Pan Tinsu, Guofang Xu, MD, Francisco Vega, MDPhD, Christopher Flowers, MDMS, Michael Wang, MD. Comprehensive Analysis of Factors Predictive for Time to Transformation and Risk of Transformation in Patients (pts) with Mantle Cell Lymphoma. Blood(Blood (2020) 136 (Supplement 1): 41–42), 2020.
- Samer A. Srour, MD MS, Jie Xu, MD, Taha Al-Juhaishi, MD, Raphael Eric Steiner, MD, Joe Ensor, PhD, Sairah Ahmed, MD, Simrit Parmar, MD, MSCI, Paolo Strati, MD, Loretta J. Nastoupil, MD, Yago Nieto, MD, Chitra Hosing, MD, Hun Ju Lee, MD, Jason Westin, MD, Nathan H. Fowler, MD, Luis Fayad, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD PhD, Jillian R. Gunther, MD PhD, Penny Fang, MD, Felipe Samaniego, MD, Preetesh Jain, MBBS,MDDM,PhD, Richard E. Champlin, MD, Issa F. Khouri, MD, Michael Wang, MD, Roberto N. Miranda, MD, Francisco Vega, MDPhD, Sattva S. Neelapu, MD, Christopher Flowers, MDMS, Swami P. Iyer, MD. Retrospective Review of Prognostic and Predictors Markers in Newly Diagnosed Angioimmunoblastic T Cell Lymphoma at UT MD Anderson Cancer Center. Blood(Blood (2020) 136 (Supplement 1): 27–28), 2020.
- Samer Al Hadidi, MDMSc,FACP, Ranjit Nair, MD, Raphael E Steiner, MD, Sairah Ahmed, MD, Paolo Strati, MD, Simrit Parmar, MD, MSCI, Swami P. Iyer, MD, Jillian R. Gunther, MD PhD, Chelsea C. Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Yago Nieto, MD, Felipe Samaniego, MD, Branko Cuglievan, MD, Preetesh Jain, MBBS,MDDM,PhD, Penny Fang, MD, Roberto N. Miranda, MD, Jeffrey Medeiros, MD, Lei Feng, MS, Hubert Chuang, MDPhD, Michael Wang, MD, Hun Ju Lee, MD. Association of Epstein-Barr Virus with Advanced Stage and Survival Outcomes in Classic Hodgkin's Lymphoma. Blood(Blood (2020) 136 (Supplement 1): 37–38), 2020.
- Sushanth Gouni, MD, Paolo Strati, MD, Jason Westin, MD, Loretta J. Nastoupil, MD, Raphael E Steiner, MD, Ranjit Nair, MD, Luis Fayad, Sattva S. Neelapu, MD, Ralf Landgraf, PhD, Daniel Bilbao, PhD, Francisco Vega, MDPhD, Nitin Agarwal, PhD. Use of Medium Potency Statins Is Associated with Improved Outcomes after Frontline RCHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL). Blood(Blood (2020) 136 (Supplement 1): 45), 2020.
- Samer Al Hadidi, MDMSc,FACP, Ranjit Nair, MD, Raphael E Steiner, MD, Sairah Ahmed, MD, Paolo Strati, MD, Simrit Parmar, MD, MSCI, Swami P. Iyer, MD, Jillian R. Gunther, MD PhD, Chelsea C. Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Yago Nieto, MD, Felipe Samaniego, MD, Branko Cuglievan, MD, Preetesh Jain, MBBS,MDDM,PhD, Penny Fang, MD, Roberto N. Miranda, MD, L. Jeffrey Medeiros, MD, Lei Feng, MS, Hubert Chuang, MDPhD, Michael Wang, MD, Hun Ju Lee, MD. Association of Smoking with Advanced Stage and Survival Outcomes in Classic Hodgkin's Lymphoma. Blood(Blood (2020) 136 (Supplement 1): 34–35), 2020.
- Vivian Changying Jiang, PhD, Shaojun Zhang, PhD, Junwei Lian, PhD, Yuanxin Wang, Rongjia Zhang, Yang Liu, PhD, Joseph McIntosh, BS, Guangchun Han, Ruiping Wang, PhD, David Santos, Maria Badillo, MSN, RN, OCN, CCRP, Angela Leeming, Zhihong Chen, Kimberly Hartig, John Bigcal, Hun Lee, MD, Raphael Eric Steiner, MD, Jorge Enrique Romaguera, MD, Preetesh Jain, MBBS,MDDM,PhD, Krystle Nomie, PhD, Andy Futreal, Linghua Wang, MDPhDMS, Michael Wang, MD. Single Cell Transcriptomic Evolution and Resistance Mechanisms of BTK and BCL-2 Inhibition in Mantle Cell Lymphoma. Blood(Blood (2020) 136 (Supplement 1): 33–34), 2020.
- Swami P. Iyer, MD, Jie Xu, MD, Melody R. Becnel, MD, Ranjit Nair, MD, Raphael Steiner, MD, Lei Feng, MS, Hun Ju Lee, MD, Paolo Strati, MD, Sairah Ahmed, MD, Simrit Parmar, MD, MSCI, Yago Nieto, MD, Chitra Hosing, MD, Jason Westin, MD, Loretta J. Nastoupil, MD, Ann Vo, Felipe Samaniego, MD, Nathan H. Fowler, MD, Neeraj Saini, MD, Issa F. Khouri, MD, Jin S. Im, Preetesh Jain, MBBS,MDDM,PhD, Luis Fayad, Michael Wang, MD, Roberto N. Miranda, MD, Francisco Vega, MDPhD, Christopher Flowers, MDMS, Sattva S. Neelapu, MD. A Phase II Study of Pembrolizumab in Combination with Romidepsin Demonstrates Durable Responses in Relapsed or Refractory T-Cell Lymphoma (TCL). Blood(Blood (2020) 136 (Supplement 1): 40–41), 2020.
- Raphael Eric Steiner, MD, Melody R. Becnel, MD, Branko Cuglievan, MD, Ranjit Nair, Prachee Singh, Paolo Strati, MD, Preetesh Jain, MBBS,MDDM,PhD, Sairah Ahmed, MD, Felipe Samaniego, MD, Jillian R. Gunther, MD PhD, Chelsea C. Pinnix, MD PhD, Penny Fang, MD, Bouthaina S. Dabaja, MD, Lei Feng, MS, Hun Ju Lee, MD. Brentuximab Vedotin with Chemotherapy in Frontline Treatment of Classic Hodgkin Lymphoma Nodular Sclerosis Syncytial Variant. Blood(Blood (2020) 136 (Supplement 1): 28–29), 2020.
- Ranjit Nair, MD, Samer Al Hadidi, MD MSc, FACP, Raphael Eric Steiner, MD, Sairah Ahmed, MD, Paolo Strati, MD, Simrit Parmar, MD, MSCI, Swaminathan P Iyer, MD, Penny Fang, MD, Jillian R. Gunther, MD PhD, Preetesh Jain, MBBS,MDDM,PhD, Chelsea C. Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Yago Nieto, MD, Felipe Samaniego, MD, Branko Cuglievan, MD, Roberto N. Miranda, MD, L. Jeffrey Medeiros, MD, Lei Feng, MS, Hubert Chuang, MDPhD, Michael Wang, MD, Hun Ju Lee, MD. Association of Vitamin D Deficiency with Inferior Treatment Outcomes in Patients with Newly Diagnosed Classic Hodgkin Lymphoma: MD Anderson Cancer Center Experience. Blood(Blood (2020) 136 (Supplement 1): 27–28), 2020.
- Paolo Strati, MD, Grace Watson, Sandra B. Horowitz, Pharm.D., Ranjit Nair, MD, Maria Alma Rodriguez, MD, Raphael Eric Steiner, MD, Luis Fayad, Jason R. Westin, MD, Sattva S. Neelapu, MD. Clinical Efficacy of Polatuzumab Vedotin in Patients with Relapsed/Refractory Large B-Cell Lymphoma after Standard of Care Axicabtagene Ciloleucel. Blood(Blood (2020) 136 (Supplement 1): 16–17), 2020.
- Samer Al Hadidi, MDMSc,FACP, Ranjit Nair, MD, Raphael E Steiner, MD, Sairah Ahmed, MD, Paolo Strati, MD, Simrit Parmar, MD, MSCI, Swami P. Iyer, MD, Jillian R. Gunther, MD PhD, Chelsea C. Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Yago Nieto, MD, Felipe Samaniego, MD, Branko Cuglievan, MD, Preetesh Jain, MBBS,MDDM,PhD, Penny Fang, MD, Roberto N. Miranda, MD, Jeffrey Medeiros, MD, Lei Feng, MS, Hubert Chuang, MDPhD, Michael Wang, MD, Hun Ju Lee, MD. Real Life Treatment Alterations of Frontline Therapies in Classic Hodgkin's Lymphoma. Blood(Blood (2020) 136 (Supplement 1): 23–24), 2020.
- Ranjit Nair, Chelsea Camille Pinnix, Jillian Rebecca Gunther, Paolo Strati, Jason Westin, Luis Fayad, Fredrick B. Hagemeister, Swaminathan Padmanabhan Iyer, Loretta J. Nastoupil, Simrit Parmar, Maria Alma Rodriguez, Raphael Steiner, Bouthaina Shbib Dabaja, Penny Fang, Christopher Flowers, Mansoor Noorani, Lei Feng, Sattva Swarup Neelapu, Sairah Ahmed, Hun Ju Lee. M.D. Anderson experience of immune checkpoint inhibitor therapy in classical Hodgkin lymphoma. ASCO Abstract(J Clin Oncol 38: 2020 (suppl; abstr e20013)), 2020. e-Pub 2020.
- Raphael Steiner, Frederick M Cramer, Prachee Singh, Melody Becnel, Pedro E Alcedo, Collin K Chin, Branko Cuglievan, Paolo Strati, Sairah Ahmed, Felipe Samaniego, Ranjit Nair, Jillian Rebecca Gunther, Chelsea Camille Pinnix, Penny Fang, Bouthaina Shbib Dabaja, Lei Feng, Hun Ju Lee. Brentuximab vedotin with chemotherapy for advanced stage untreated classic Hodgkin’s lymphoma in a real-world setting. ASCO Abstract(J Clin Oncol 38: 2020 (suppl; abstr e20020)), 2020. e-Pub 2020.
- Sairah Ahmed, fateeha furqan, Paolo Strati, Jason Westin, Luis Fayad, Frederick B. Hagemeister, Hun Ju Lee, Swaminathan Padmanabhan Iyer, Ranjit Nair, Loretta J. Nastoupil, Simrit Parmar, Maria Alma Rodriguez, Felipe Samaniego, Raphael Steiner, Michael Wang, Chelsea Camille Pinnix, Christopher Flowers, Sandra B. Horowitz, Misha Hawkins, Sattva Swarup Neelapu. Haemophagocytic lymphohistiocytosis (HLH) in patients with large B-cell lymphoma treated with standard of care (SOC) axicabtagene ciloleucel (Axi-cel). ASCO Abstract(J Clin Oncol 38: 2020 (suppl; abstr 8057)), 2020. e-Pub 2020.
- Paolo Strati, fateeha furqan, Jason Westin, Luis Fayad, Sairah Ahmed, Hun Ju Lee, Swaminathan Padmanabhan Iyer, Ranjit Nair, Loretta J. Nastoupil, Simrit Parmar, Maria Alma Rodriguez, Felipe Samaniego, Raphael Steiner, Michael Wang, Chelsea Camille Pinnix, Christopher Flowers, Sandra B. Horowitz, Catherine Classen, Haleigh Mistry, Sattva Swarup Neelapu. Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel). ASCO Abstract(J Clin Oncol 38: 2020 (suppl; abstr 8011)), 2020.
- Jason Westin, Loretta J. Nastoupil, Luis Fayad, Fredrick B. Hagemeister, Yasuhiro Oki, Francesco Turturro, Sairah Ahmed, Maria Alma Rodriguez, Hun Ju Lee, Raphael Steiner, Ranjit Nair, Simrit Parmar, Ken H Young, Timothy McDonnell, Hubert Chuang, Michael Richard Green, Sattva Swarup Neelapu, Richard Eric Davis. Smart start: Final results of rituximab, lenalidomide, and ibrutinib lead in prior to combination with chemotherapy for patients with newly diagnosed diffuse large B-cell lymphoma. ASCO Abstract, 2019.
- Changying Jiang, PhD , Shaojun Zhang, PhD , Yuanxin Wang , Rongjia Zhang , Yang Liu, MD , Joseph Mitchell McIntosh , Guangchun Han, PhD , Ruiping Wang, PhD , David Santos , Maria Badillo , Angela Leeming , Zhihong Chen , Kimberly Hartig , John Bigcal , Hun Ju Lee , Raphael E Steiner, MD , Jorge Enrique Romaguera, MD , Preetesh Jain, MBBS, MDDM, PhD , Krystle Nomie, PhD , Andy Futreal, PhD , Linghua Wang, PhD , Michael L. Wang, MD. Transcriptomic Heterogeneity and Clonal Evolution Associated with Therapeutic Resistance in Mantle Cell Lymphoma Revealed By Single Cell RNA-Seq. Blood(Blood (2019) 134 (Supplement_1): 5217), 2019.
- Dahlia Sano, MD , Paolo Strati, MD , Pedro Alcedo, MD , V Ahalya Rao, MD , Prachee Singh , Roberto N. Miranda, MD , Jillian R Gunther, MD PhD , Chelsea Camille Pinnix, MD PhD , Bouthaina S. Dabaja, MD , Feng Lei, MS , Hun Ju Lee, MD , Raphael E Steiner, MD. Maintenance Rituximab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) in the First Line Setting or at Relapse. Blood(Blood (2019) 134 (Supplement_1): 5291), 2019.
- Loretta J. Nastoupil, MD MSc , Jason R. Westin, MD , Fredrick B. Hagemeister, MD , Hun Ju Lee , Luis Fayad, MD , Felipe Samaniego, MD , Sairah Ahmed, MD , Linda Claret , Raphael E Steiner, MD , Ranjit Nair, MBBS,MD , Simrit Parmar, MBBS , Maria Alma Rodriguez, MD , Michael L. Wang, MD , Michael R Green, PhD , Eric Davis, MD , Sattva S Neelapu, MD , Nathan H Fowler, MD. Results of a Phase II Study of Obinutuzumab in Combination with Lenalidomide in Previously Untreated, High Tumor Burden Follicular Lymphoma (FL). Blood(Blood (2019) 134 (Supplement_1): 125), 2019.
- Nathan H Fowler, MD , Loretta J. Nastoupil, MD MSc , Collin Chin, MBBS , Paolo Strati, MD , Fredrick B. Hagemeister, MD , Luis E. Fayad, MD , Jason R. Westin, MD , Sheryl G Forbes , Janine Arafat , Lei Feng, MS , Ranjit Nair, MBBS,MD , Raphael E Steiner, MD , Felipe Samaniego, MD , Sattva S Neelapu, MD. A Phase I/II Study of Lenalidomide Plus Obinutuzumab in Relapsed Indolent Lymphoma. Blood(Blood (2019) 134 (Supplement_1): 348), 2019.
- Paolo Strati, MD , Sudhakar Tummala , Loretta J. Nastoupil, MD MSc , Jason R. Westin, MD , Luis Fayad, MD , Sairah Ahmed, MD , Nathan H. Fowler, MD , F. B. Hagemeister, MD , Hun Ju Lee, MD , Swaminathan P. Iyer, MD , Ranjit Nair, MD , Simrit Parmar, MBBS , Maria Alma Rodriguez, MD , Felipe Samaniego, MD , Raphael Eric Steiner, MD , Michael L. Wang, MD , Chelsea Camille Pinnix, MD PhD , Sherry Adkins, ANP , Catherine M. Claussen, MS , Charles Martinez , Misha Hawkins , Nicole Johnson , Shirley George , Sattva S Neelapu, MD , Linda Chi, MD. Clinical and Radiological Correlates of Neurotoxicity after Standard of Care Axicabtagene Ciloleucel in Patients with Relapsed/Refractory Large B-Cell Lymphoma. Blood(Blood (2019) 134 (Supplement_1): 765), 2019. e-Pub 2019.
- Chelsea C Pinnix, MD PhD , Jillian R Gunther, MD PhD , Bouthaina S. Dabaja, MD , Sherry Adkins, ANP , Misha Hawkins , Jason R. Westin, MD , Luis Fayad, MD , Sairah Ahmed, MD , Nathan H. Fowler, MD , Fredrick B. Hagemeister, MD , Swaminathan P. Iyer, MD , Maria Alma Rodriguez, MD , Hun Ju Lee , Raphael E Steiner, MD , Ranjit Nair, MBBS,MD , Paolo Strati, MD , Simrit Parmar, MBBS , Felipe Samaniego, MD , Michael Wang, MD , Sattva S Neelapu, MD , Loretta J. Nastoupil, MD MSc. Radiation Therapy Can be an Effective Bridging Strategy Prior to Axicabtagene Ciloleucel Therapy for Relapsed/Refractory Large B-Cell Lymphoma. Blood(Blood (2019) 134 (Supplement_1): 1609), 2019. e-Pub 2019.
- Jason R. Westin, MD , Loretta J. Nastoupil, MD MSc , Luis Fayad, MD , Fredrick B. Hagemeister, MD , Yasuhiro Oki, MD , Francesco Turturro, MD , Sairah Ahmed, MD , Maria Alma Rodriguez, MD , Hun Ju Lee , Raphael Eric Steiner, MD , Ranjit Nair, MBBS,MD , Simrit Parmar, MBBS , Ken H. Young , Timothy J. McDonnell, MD PhD , Hubert Chuang , Michael R Green, PhD , Sattva S Neelapu, MD , Eric Davis, MD. Smart Start: Rituximab, Lenalidomide, and Ibrutinib Alone and in Combination with Standard Chemotherapy for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: Final Phase II Results. Blood(Blood (2019) 134 (Supplement_1): 1581), 2019.
- Preetesh Jain, MBBS,MDDM,PhD , Hun Ju Lee, MD , Raphael Eric Steiner, MD , F. B. Hagemeister, MD , Felipe Samaniego, MD , Jason R. Westin, MD , Loretta J. Nastoupil, MD MSc , Sairah Ahmed, MD , Swaminathan P. Iyer, MD , Jorge Enrique Romaguera, MD , Shuangtao Zhao, PhD , Krystle Nomie, PhD , Chi Young Ok, MD , Rashmi Kanagal-Shamanna, MD , Onyeka Oriabure , Guofang Xu, MD , Liang Zhang, MD PhD , Changying Jiang, PhD , Dayoung Jung , Lucy Navsaria, MB BCh BAO , Wendy Chen , Omar Moghrabi , Tayyaba Nizam , Chloe Marie McClain , Maria Badillo , Selvi Thirumurthi , David Santos , Guilin Tang, MD , Keyur Patel, MD PhD , Sattva S Neelapu, MD , Linghua Wang, PhD , Nathan H. Fowler, MD , Michael L. Wang, MD. Frontline Treatment with Ibrutinib with Rituximab (IR) Combination Is Highly Effective in Elderly (≥65 years) Patients with Mantle Cell Lymphoma (MCL) - Results from a Phase II Trial. Blood(Blood (2019) 134 (Supplement_1): 3988), 2019.
- Preetesh Jain, MBBS,MDDM,PhD , Shuangtao Zhao, PhD , Rashmi Kanagal-Shamanna, MD , Lucy Navsaria, MB BCh BAO , Holly Hill , Ankita Misra , Krystle Nomie, PhD , Changying Jiang, PhD , Yixin Yao, PhD , Liang Zhang, MD PhD , Loretta J. Nastoupil, MD MSc , F. B. Hagemeister, MD , Jason R. Westin, MD , Ranjit Nair, MD , Raphael Eric Steiner, MD , Onyeka Oriabure , Wendy Chen , Guilin Tang, MD , C. Cameron Yin, MD PhD , Keyur Patel, MD PhD , Jorge Enrique Romaguera, MD , Nathan H. Fowler, MD , Linghua Wang, PhD , Michael L. Wang, MD. Non-Bcl2 Mutations Are Predominant in Patients (pts) with Venetoclax Resistant Mantle Cell Lymphoma (MCL) - Response and Clinical Outcomes in Ultra-Refractory MCL. Blood(Blood (2019) 134 (Supplement_1): 2815), 2019.
- Ariela Noy, MD , Timothy S. Pardee, MD PhD , Liana Nikolaenko, MD , Raphael Eric Steiner, MD , Jeremy S. Abramson, MD MMSc , Kieron Dunleavy, MD , Sanjeev Luther, MBA. A Phase II Clinical Trial of Cpi-613 (devimistat) in Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma with Rearrangements of MYC and BCL2and/or BCL6. Blood(Blood (2019) 134 (Supplement_1): 4087), 2019.
- Jason R. Westin, MD , Nathan H. Fowler, MD , Loretta J. Nastoupil, MD MSc , Sattva S Neelapu, MD , Hun Ju Lee , Fredrick B. Hagemeister, MD , Maria Alma Rodriguez, MD , Raphael E Steiner, MD , Sairah Ahmed, MD , Simrit Parmar, MBBS , Ranjit Nair, MBBS,MD , Rebecca Harrison, MD , Luis Fayad, MD. A Phase II Trial of Nivolumab and Ibrutinib for Patients with Relapsed or Refractory Central Nervous System Lymphoma. Blood(Blood (2019) 134 (Supplement_1): 4086), 2019.
- P. Strati, P. Alcedo Andreade, D. Sano, V. Rao, P. Singh, R. Miranda, J. Gunther, C. Pinnix, B. Dabaja, H.J. Lee, R. Steiner. RELAPSED AND REFRACTORY NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA (NLPHL): A US ANALYSIS FROM MD ANDERSON CANCER CENTER. Hematological ONCOLOGY ICML Abstract(Abstract No: 471), 2019.
- B. Dabaja, M. Gule-Monroe, J.R. Gunther, S. Milgrom, T. Sheu, R. Nair, S. Ahmed, R. Steiner, P. Strati, L. Nastoupil, S. Neelapu, C. Pinnix, N. Fowler. DIFFUSE LARGE B CELL LYMPHOMA WITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT: CAN MRI PATTERN HELP PREDICTING OUTCOME?. Hematological ONCOLOGY ICML Abstract(Abstract No: 406), 2019.
- J.R. Westin, L. Nastoupil, L. Fayad, F. Hagemeister, K. Young, T. McDonnell, S. Neelapu, R.E. Davis, M. Green, S. Ahmed, R. Nair, R. Steiner, H. Lee, M. Rodriguez, S. Parmar, H. Chuang. VERY EARLY FDG PET/CT SCAN MAY PREDICT OUTCOMES IN RELAPSED OR REFRACTORY DLBCL PATIENTS TREATED WITH SALVAGE THERAPY. Hematological ONCOLOGY ICML Abstract(Abstract No: 367), 2019.
- J.R. Westin, L. Nastoupil, F. Hagemeister, L. Fayad, K. Young, T. McDonnell, H. Chuang, S. Ahmed, R. Nair, R. Steiner, H. Lee, M. Rodriguez, S. Parmar, M. Green, S. Neelapu, R. Davis. SMART START: RITUXIMAB, LENALIDOMIDE, AND IBRUTINIB ALONE PRIOR TO COMBINATION WITH CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA. Hematological ONCOLOGY ICML Abstract(Abstract No: 042), 2019.
- Kartik Anand, Ethan Burns, Dahlia Sano, Sai Ravi Pingali, Jason Westin, Loretta J. Nastoupil, Hun Ju Lee, Felipe Samaniego, Simrit Parmar, Michael Wang, Misha Hawkins, Sherry Adkins, Luis Fayad, Raphael Steiner, Ranjit Nair, Sairah Ahmed, Nathan Hale Fowler, Sattva Swarup Neelapu, Swaminathan Padmanabhan Iyer;. Comprehensive report of anti-CD19 chimeric antigen receptor T cells (CAR-T) associated non-relapse mortality (CART-NRM) from FAERS. ASCO Abstract(Abstract No: 2540), 2019.
- Dahlia Sano, Loretta J. Nastoupil, Nathan H. Fowler, Luis Fayad, F. B. Hagemeister, Hun Ju Lee, Felipe Samaniego, Michael Wang, Maria Alma Rodriguez, Swaminathan P Iyer, Simrit Parmar, Raphael Steiner, Ranjit Nair, Sherry Adkins, Sara Arafat, Ahalya Rao, Liliana Vallejo, Misha Hawkins, Yiming Chen, Jason R. Westin, and Sattva S. Neelapu. Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell LymphomaClinically Relevant Abstract. ASH Annual Meeting 2018, 2018.
- Steiner RE, Fanale MA. New Strategies for the Treatment of Early Stage Classical Hodgkin Lymphoma (cHL). Clinical Lymphoma, Myeloma & Leukemia 17:S153–S155. e-Pub 2017.
- Chaudhry M, Steiner RE, Claussen CM, Patel K, Lee HC, Weber DM, Thomas SK, Feng C, Kramer M, Amini B, Orlowski RZ, Feng L, Manasanch EE. Carfilzomib-Based Combination Regimens Are Highly Effective Frontline Therapies for Multiple Myeloma and Waldenström's Macroglobulinemia. ASH Abstract 130(Suppl 1):1880. e-Pub 2017.
Book Chapters
- Raphael Steiner, Jason R. Westin, Sergej N. Konoplev, Luis E. Fayad, L. Jeffrey Medeiros. Aggressive B-Cell Lymphomas. In: The MD Anderson Manual of Medical Oncology, Fourth Edition 4th Edition. McGraw Hill / Medical; 4th edition (April 22, 2022), 2022.
- M. Khan, J. Westin, R. Steiner. Lymphoma. In: Handbook of Targeted Cancer Therapy and Immunotherapy. 3rd. Wolters Kluwer Health; 3rd edition (March 28, 2022), 2022.
- Raphael Steiner, Xiaochun Liu, Jason R. Westin. Lymphoma. In: Handbook of Targeted Cancer Therapy and Immunotherapy. second. Wolters Kluwer, 2018.
Grant & Contract Support
Title: | |
Funding Source: | Swiss Transplant Cohort Study |
Role: | Principal Investigator |